392 related articles for article (PubMed ID: 20444197)
21. Melanocytes in development and cancer.
Uong A; Zon LI
J Cell Physiol; 2010 Jan; 222(1):38-41. PubMed ID: 19795394
[TBL] [Abstract][Full Text] [Related]
22. Protooncogene MYC drives human melanocyte melanogenesis and senescence.
San Juan L; Cagigal ML; Fernandez-Flores A; Mayorga M; Gandarillas A
Cancer Gene Ther; 2022 Aug; 29(8-9):1160-1167. PubMed ID: 35022520
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes.
Fufa TD; Harris ML; Watkins-Chow DE; Levy D; Gorkin DU; Gildea DE; Song L; Safi A; Crawford GE; Sviderskaya EV; Bennett DC; Mccallion AS; Loftus SK; Pavan WJ
Hum Mol Genet; 2015 Oct; 24(19):5433-50. PubMed ID: 26206884
[TBL] [Abstract][Full Text] [Related]
24. The Roles of Sox Family Genes in Sarcoma.
Li J; Shen J; Wang K; Hornicek F; Duan Z
Curr Drug Targets; 2016; 17(15):1761-1772. PubMed ID: 27138764
[TBL] [Abstract][Full Text] [Related]
25. Transcription factors from Sox family regulate expression of zebrafish Gla-rich protein 2 gene.
Fazenda C; Conceição N; Cancela ML
Gene; 2015 Nov; 572(1):57-62. PubMed ID: 26143119
[TBL] [Abstract][Full Text] [Related]
26. An Integrative Developmental Genomics and Systems Biology Approach to Identify an In Vivo Sox Trio-Mediated Gene Regulatory Network in Murine Embryos.
Lee WJ; Chatterjee S; Yap SP; Lim SL; Xing X; Kraus P; Sun W; Hu X; Sivakamasundari V; Chan HY; Kolatkar PR; Prabhakar S; Lufkin T
Biomed Res Int; 2017; 2017():8932583. PubMed ID: 28630873
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of normal melanocytes and melanoma cells.
Bandarchi B; Jabbari CA; Vedadi A; Navab R
J Clin Pathol; 2013 Aug; 66(8):644-8. PubMed ID: 23526597
[TBL] [Abstract][Full Text] [Related]
28. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
29. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
30. The role of sex-determining region Y-box 6 in melanogenesis in alpaca melanocytes.
Du B; Liu X; Zhang P; Zhang J; Ji K; Hu S; Yang S; Liu B; Fan R
J Dermatol Sci; 2018 Sep; 91(3):268-275. PubMed ID: 29857961
[TBL] [Abstract][Full Text] [Related]
31. Deciphering the Sox-Oct partner code by quantitative cooperativity measurements.
Ng CK; Li NX; Chee S; Prabhakar S; Kolatkar PR; Jauch R
Nucleic Acids Res; 2012 Jun; 40(11):4933-41. PubMed ID: 22344693
[TBL] [Abstract][Full Text] [Related]
32. A new transgenic mouse line for tetracycline inducible transgene expression in mature melanocytes and the melanocyte stem cells using the Dopachrome tautomerase promoter.
Woods SL; Bishop JM
Transgenic Res; 2011 Apr; 20(2):421-8. PubMed ID: 20577802
[TBL] [Abstract][Full Text] [Related]
33. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
34. Polycomb group proteins--epigenetic repressors with emerging roles in melanocytes and melanoma.
Huang JM; Hornyak TJ
Pigment Cell Melanoma Res; 2015 May; 28(3):330-9. PubMed ID: 25475071
[TBL] [Abstract][Full Text] [Related]
35. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.
Huber WE; Price ER; Widlund HR; Du J; Davis IJ; Wegner M; Fisher DE
J Biol Chem; 2003 Nov; 278(46):45224-30. PubMed ID: 12944398
[TBL] [Abstract][Full Text] [Related]
36. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
[TBL] [Abstract][Full Text] [Related]
37. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
38. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
39. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
40. Melanocytes, melanocyte stem cells, and melanoma stem cells.
Lang D; Mascarenhas JB; Shea CR
Clin Dermatol; 2013; 31(2):166-78. PubMed ID: 23438380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
